Q-VANT Biosciences

Q-VANT Biosciences is a biotechnology company specializing in the sustainable production of high-purity saponin-based adjuvants, most notably QS-21. Utilizing its proprietary Q-VANT™ platform, the company addresses the global supply chain challenges of Quillaja saponaria-derived compounds through advanced extraction and purification technologies. Their tree-to-vial approach ensures a scalable and environmentally friendly supply of critical vaccine components used in blockbuster vaccines for shingles, malaria, and various oncology applications. Q-VANT aims to become the leading global supplier of pharmaceutical-grade saponins for the next generation of immunotherapies and vaccines.